Search all trials

Find therapies in clinical trials near you – page 6

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Cachexia

Not recruiting

Investigational

Study of ponsegromab for patients with cancer cachexia and elevated GDF-15 levels

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Ponsegromab

Contact Research Centre

Hepatic cirrhosis

Not recruiting

Registered drug

Study on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Dapagliflozin

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study on Long-Term Use of Spesolimab for Patients with Hidradenitis Suppurativa Who Completed a Previous Spesolimab Study

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Spesolimab

Contact Research Centre

Relapsing multiple sclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Registered drug

Slovakia

Participants:18–64 years
Substances:Charcoal, Activated

Contact Research Centre

Multiple sclerosis relapse

Not recruiting

Registered drugNo placebo

Study on Ofatumumab for Patients with Relapsing Multiple Sclerosis Transitioning from Fumarate-Based Therapies or Fingolimod

Registered drugNo placebo

Slovakia

Participants:18–64 years
Substances:Ofatumumab

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Registered drug

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Apixaban

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure

Investigational

Slovakia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Upadacitinib

Contact Research Centre

Multiple sclerosis+2

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Ocrelizumab, Methylprednisolone, and Diphenhydramine Hydrochloride in Patients with Multiple Sclerosis

Registered drugNo placebo

Slovakia

Participants:18–64 years
Substances:Methylprednisolone

Contact Research Centre

Lung disorder

Not recruiting

Registered drug

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Baricitinib

Contact Research Centre

Lung disorder

Not recruiting

Investigational

Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Bemcentinib

Contact Research Centre

Breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Registered drugNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Fulvestrant

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Spesolimab

Contact Research Centre

Find therapies in clinical trials near you – page 6

77 trials match your criteria

Cachexia

Study of ponsegromab for patients with cancer cachexia and elevated GDF-15 levels

Hepatic cirrhosis

Study on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis

Hidradenitis

Study on Long-Term Use of Spesolimab for Patients with Hidradenitis Suppurativa Who Completed a Previous Spesolimab Study

Relapsing multiple sclerosis

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Multiple sclerosis relapse

Study on Ofatumumab for Patients with Relapsing Multiple Sclerosis Transitioning from Fumarate-Based Therapies or Fingolimod

Atrial fibrillation+2

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Hidradenitis

Study on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure

Multiple sclerosis+2

Study on the Effectiveness and Safety of Ocrelizumab, Methylprednisolone, and Diphenhydramine Hydrochloride in Patients with Multiple Sclerosis

Lung disorder

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Lung disorder

Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Breast cancer

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Hidradenitis

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.